Anisaldehyde

Anisaldehyde

SCHEMBL1477047

COc1ccc(C=O)cc1.[KH]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.95
CYP2A6 P11509 2/20 0.95
ALDH1A3 P47895 1/20 0.56
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA7 P43166 1/20 0.55
CA9 Q16790 1/20 0.55
CA14 Q9ULX7 1/20 0.55
TSHR P16473 2/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
CYP3A4 P08684 1/20 0.54
KDM4E B2RXH2 1/20 0.54
TRPA1 O75762 1/20 0.52
RELA Q04206 1/20 0.52
F3 P13726 1/20 0.52
ESR1 P03372 2/20 0.50
ABL1 P00519 1/20 0.50
TTR P02766 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anisaldehyde SCHEMBL717471 0.97 ALDH1A1 (1.00) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL1100 0.97 ALDH1A1 (1.00) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL28557435 0.95 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL31123393 0.95 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL28523745 0.95 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL1475478 0.95 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL11255570 0.95 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL28556480 0.95 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL29966134 0.95 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3CA12CA1
Anisaldehyde SCHEMBL28776745 0.95 ALDH1A1 (0.95) ALDH1A1CYP2A6ALDH1A3CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7915274-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-03-29 US disclosed
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same OZAKI FUMIHIRO 2007-12-20 US disclosed
US-7265108-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2007-09-04 US disclosed
EP-1484327-B1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF EISAI R&D MAN CO LTD (JP) 2007-08-01 EP disclosed
US-6995144-B2 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI CO., LTD. (JP) 2006-02-07 US disclosed
US-20050245527-A1 Nitrogen containing heterocyclic compounds and medicines containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-03 US disclosed
EP-1484327-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF Eisai Co., Ltd. (JP) 2004-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293496-A1 Nitrogen containing heterocyclic compounds and medicines containing the same XDH, NQO1, CYP1A1 ALDH1A1 363/4885CYP2A6 73/4885ALDH1A3 2636/4885
US-20050245527-A1 Nitrogen containing heterocyclic compounds and medicines containing the same XDH, NQO1, CYP1A1 ALDH1A1 363/4885CYP2A6 73/4885ALDH1A3 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.